(3aR*,4R*,6R*,6aR*)-Ethyl -6-hydroxy-2-phenyl-4,5,6,6a-tetrahydro-3aH-cyclo-
penta[d]oxazole-4-carboxylate ((±)-2)
White solid; yield 73%; R f = 0.47 (n-hexane/EtOAc 1:2); Mp 99-105 °C. (3aS*,4R*,6S*,6aR*)-Ethyl -6-fluoro-2-phenyl-4,5,6,6a-tetrahydro-3aH-cyclo-
penta[d]oxazole-4-carboxylate ((±)-3)
Yellowish white solid; 25%; R f = 0.65 (n-hexane/acetone 2:1); Mp 84-87 °C. 
S12
X-ray structure determination. The crystal of (±)-5 was immersed in cryo-oil, mounted in a MiTeGen loop, and measured at 120 K on a Rigaku Oxford Diffraction Supernova diffractometer using CuK ( = 1.54184 Å) radiation. The CrysAlisPro program package was used for cell refinement and data reduction. An analytical absorption correction (CrysAlisPro [1] ) was applied to the intensities before structure solution. The structure was solved by intrinsic phasing method using SHELXT software. Structural refinement was carried out using SHELXL-2016 [2] . The O-H and N-H hydrogen atoms were located from the difference Fourier map and refined isotropically. All other H-atoms were positioned geometrically and constrained to ride on their parent atoms, with C-H = 0.95-1.00 Å and U iso = 1.2-1.5U eq (parent atom).
The crystallographic details are summarized in Table S1 . 
